Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Antiviral Therapy|November 14, 2015
Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort studySandrine Gazaignes, Matthieu Resche-Rigon, Caroline Gatey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2023
A Randomized Controlled Trial to Study the Transmission of SARS-CoV-2 and Other Respiratory Viruses During Indoor Clubbing Events (ANRS0066s ITOC Study)Liem Binh Luong Nguyen, Jeanne Goupil de Bouillé, Lola Menant, et al.
Journal of Clinical Virology Plus|March 9, 2022
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result testsHonorine Fenaux, Théo Ghelfenstein-Ferreira, Maud Salmona, et al.
AIDS (London, England)|March 13, 2009
Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in FranceMarie-Laure Chaix, Diane Descamps, Marc Wirden, et al.
Journal of Medical Virology|September 21, 2005
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097)Constance Delaugerre, Gilles Peytavin, Stephanie Dominguez, et al.
Retrovirology|September 22, 2009
Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcomeConstance Delaugerre, Marie-Laure Chaix, Stephane Blanche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2021
Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal CohortLorenza N C Dezanet, Raisha Kassime, Patrick Miailhes, et al.
Journal of Clinical Microbiology|June 7, 2003
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIsMarc Wirden, Anne Simon, Luminita Schneider, et al.
AIDS (London, England)|April 13, 2004
Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097)Christine Katlama, Stéphanie Dominguez, Karine Gourlain, et al.
The Journal of Infectious Diseases|April 25, 2025
Investigating nosocomial BKPyV (BK Polyomavirus) infections in pediatric hematopoietic stem cell transplantation recipients: challenges and prospectsAurélien Aubry, Marie-Laure Nere, Sarah Timsit, et al.
Pageof 23